RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Motzer, R.; Alyasova, A.; Ye, D. W.; Karpenko, A.; Li, H. Z.; Alekseev, B. Y.; Xie, L. P.; Kurteva, G. P.; Kowalyszyn, R. D.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Segal, S.; Morgan, L. M.; Yang, L.
Abstract Title: RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036900986
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.4518
Notes: Meeting Abstract: 4518 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer